EyePoint Pharmaceuticals
EYPT
EYPT
46 hedge funds and large institutions have $20.8M invested in EyePoint Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
Holders
46
Holding in Top 10
–
Calls
$1.05M
Puts
$312K
Top Buyers
| 1 | +$1.29M | |
| 2 | +$505K | |
| 3 | +$323K | |
| 4 |
Bank of New York Mellon
New York
|
+$111K |
| 5 |
SIM
Spark Investment Management
New York
|
+$94.1K |
Top Sellers
| 1 | -$442K | |
| 2 | -$317K | |
| 3 | -$233K | |
| 4 |
Two Sigma Investments
New York
|
-$232K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$159K |